CVRx (CVRX) Cost of Revenue (2020 - 2026)
CVRx's (CVRX) quarterly Cost of Revenue came in at $1.9 million in Q1 2026, down 7.27% year-on-year from $2.0 million in Q1 2025, and down 14.14% quarter-over-quarter from $2.2 million in Q4 2025.
CVRx (CVRX) Cost of Revenue (2020 - 2026) Analysis & Trends
CVRx's Cost of Revenue history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- On a quarterly basis, Cost of Revenue fell 7.27% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 6.76% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, changed 0.28% from the prior year.
- Cost of Revenue eased to $1.9 million in Q1 2026 per CVRX's latest filing, from $2.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $2.6 million in Q4 2024 and bottomed at $949000.0 in Q1 2022.
- The 5-year median for Cost of Revenue is $1.7 million (2023), against an average of $1.8 million.
- Across the five-year window, Cost of Revenue surged 53.35% in 2022 and slipped 14.47% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $1.5 million in 2022, then gained by 13.98% to $1.7 million in 2023, then surged by 49.48% to $2.6 million in 2024, then declined by 14.47% to $2.2 million in 2025, then slipped by 14.14% to $1.9 million in 2026.
- Per Business Quant, the three latest CVRX Cost of Revenue figures stand at $1.9 million (Q1 2026), $2.2 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Dec 31, 2023 | 1.72 Mn |